Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
House Energy and Commerce Committee Chair Cathy McMorris Rodgers criticized President Biden for undermining the Cancer Moonshot Initiative with the IRA price-setting scheme. In a statement following Biden's comments on the issue during his State of the Union Address, Rodgers expressed her concerns about the impact of the price-setting scheme on innovation in the healthcare industry.
Rodgers stated, "American leads the world in biomedical innovation, producing cutting-edge devices, treatments, and cures for new diseases and conditions every year. Rather than support the research and development of new cures, President Biden and Congressional Democrats forced through a partisan price-setting scheme that is already harming innovation and robbing patients of hope."
She further highlighted the contradiction in Biden's support for the Cancer Moonshot Initiative while implementing laws and regulations that hinder its progress. Rodgers emphasized the urgency of the situation, stating, "Patients battling cancer now can't afford to wait. The President must work with Congressional Republicans to lower drug costs by undoing the worst parts of the Inflation Reduction Act—it's how we restore hope for patients, families, and caregivers."
As the debate over healthcare policies continues, stakeholders are closely monitoring the developments and potential changes to the IRA price-setting scheme. The call for collaboration between the President and Congressional Republicans to address concerns about drug costs reflects the ongoing efforts to balance innovation with affordability in the healthcare sector.
Alerts Sign-up